Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 3 results.
User Information
Export Records
  1. 1.   ERK signaling promotes resistance to TRK kinase inhibition in NTRK fusion-driven glioma mouse models
  2. Schmid, Sebastian; Russell, Zachary R; Shimura Yamashita,Alex; West, Madeline E; Parrish, Abigail G; Walker, Julia; Rudoy, Dmytro; Yan, James Z; Quist, David C; Gessesse, Betemariyam N; Alvinez, Neriah; Hill, Kimberly D; Anderson,Larry; Cimino, Patrick J; Kumasaka, Debra K; Parchment,Ralph; Holland, Eric C; Szulzewsky, Frank
  3. Cell Reports. 2024, Oct 03; 43(10): 114829.
  1. 2.   Efficacy, Tolerability, and Pharmacokinetics of Combined Targeted MEK and Dual mTORC1/2 Inhibition in a Preclinical Model of Mucosal Melanoma
  2. Wei,Bih; Hoover, Shelley B.; Peer, Cody J.; Dwyer, Jennifer E.; Adissu, Hibret A.; Shankarappa, Priya; Yang, Howard; Lee, Maxwell; Peat, Tyler J.; Figg, William D.; Simpson, R. Mark
  3. MOLECULAR CANCER THERAPEUTICS. 2020, NOV 1; 19(11): 2308-2318.
  1. 3.   MEK inhibitor trametinib in combination with gemcitabine regresses a patient-derived orthotopic xenograft (PDOX) pancreatic cancer nude mouse model
  2. Kawaguchi, Kei; Igarashi, Kentaro; Miyake, Kentaro; Lwin, Thinzar M; Miyake, Masuyo; Kiyuna, Tasuku; Hwang, Ho Kyoung; Murakami, Takashi; Delong, Jonathan C; Singh, Shree Ram; Clary, Bryan; Bouvet, Michael; Unno, Michiaki; Hoffman, Robert M
  3. Tissue & cell. 2018, Jun; 52: 124-128.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel